CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...

A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

The European Medicines Agency’s (EMA’) human medicines committee (CHMP) has recommended two new medicines and three ...

Ala Ebtekar’s new cyanotypes for Arion Press were exposed using moon and starlight during a partial lunar eclipse ...

Akebia Therapeutics, Inc.’s AKBA share price has dipped by 28.17%, which has investors questioning if this is right time to ...

If you’ve searched for places to buy Viagra online, you’ve surely also noticed its price tag. Since Viagra is a brand-name medication, the price of Viagra is very high and may not currently ...

Auryxia® (ferric citrate) net product revenues were $44.4 million in the fourth quarter of 2024 compared to $53.2 million in the fourth quarter of 2023, and $152.2 million for the full-year 2024 ...

In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “V ...